Cargando…
Three‐year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan
The Japanese national and prefectural governments have accredited high‐capacity, high‐experience cancer care hospitals as “designated cancer care hospitals” to standardize cancer care, centralize patients, and improve clinical outcomes, but the performance of these designated hospitals has not been...
Autores principales: | Okawa, Sumiyo, Tabuchi, Takahiro, Nakata, Kayo, Morishima, Toshitaka, Koyama, Shihoko, Odani, Satomi, Miyashiro, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177783/ https://www.ncbi.nlm.nih.gov/pubmed/33570834 http://dx.doi.org/10.1111/cas.14847 |
Ejemplares similares
-
Minimum surgical volume to ensure 5‐year survival probability for six cancer sites in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022) -
Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022) -
Between-hospital variations in 3-year survival among patients with newly diagnosed gastric, colorectal, and lung cancer
por: Morishima, Toshitaka, et al.
Publicado: (2022) -
Hospital volume and postoperative 5‐year survival for five different cancer sites: A population‐based study in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2020) -
Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
por: Odani, Satomi, et al.
Publicado: (2021)